Corbus Pharmaceuticals Inc.
CRBP | NASDAQ
$7.79
+$0.14 (+1.83%)
Sep 22, 2026, 1:33 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 28.49M | 17.2M | 13.72M | 17M | 25.01M | 85.43M |
Short-Term Investments | 134.78M | 131.86M | 7.18M | 42.19M | 72.64M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 669.9K |
Other Long-Term Assets | n/a | 385K | 690K | 632.77K | 523.81K | 234.04K |
Receivables | 1.5M | n/a | n/a | n/a | n/a | 2.58M |
Inventory | n/a | n/a | n/a | n/a | n/a | 350K |
Other Current Assets | 1.52M | 3.91M | 192K | 192.48K | 192.48K | n/a |
Total Current Assets | 166.95M | 152.98M | 23.55M | 60.18M | 100.2M | 92.07M |
Property-Plant & Equipment | 1.24M | 2.52M | 4.04M | 5.5M | 7M | 9.32M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.24M | 2.9M | 4.73M | 6.13M | 7.53M | 10.22M |
Total Assets | 168.2M | 155.88M | 28.27M | 66.31M | 107.73M | 102.29M |
Account Payables | 2.22M | 4.79M | 3.18M | 2.17M | 1.78M | 7.38M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 16.21M | 3.15M | 3.86M | 710.16K |
Other Current Liabilities | 2.86M | 2.28M | 39K | 36.87K | 133.71K | 797K |
Total Current Liabilities | 20.69M | 11.82M | 31.89M | 12.64M | 17.01M | 31.9M |
Long-Term Debt | n/a | n/a | n/a | 15.98M | 15.64M | 18.03M |
Other Long-Term Liabilities | n/a | n/a | 44K | 22.21K | 22.21K | n/a |
Total Long-Term Liabilities | n/a | 1.63M | 3.28M | 20.68M | 21.61M | 25.12M |
Total Liabilities | 20.69M | 13.45M | 35.18M | 33.32M | 38.62M | 57.02M |
Total Debt | 1.63M | 3.24M | 20.89M | 25.09M | 26.59M | 26.84M |
Book Value | 147.5M | 142.43M | -6.91M | 32.99M | 69.11M | 45.27M |
Book Value Per Share | 11.08 | 13.05 | -1.60 | 7.91 | 16.86 | 17.38 |
Common Stock | 2K | 1K | n/a | 417 | 12.52K | 9.89K |
Retained Earnings | -555.43M | -476.89M | -436.68M | -392.08M | -349.73M | -304.09M |
Comprehensive Income | -53K | 35K | -1K | -126.09K | -62.45K | n/a |
Shareholders Equity | 147.5M | 142.43M | -6.91M | 32.99M | 69.11M | 45.27M |
Total Investments | 134.78M | 131.86M | 7.18M | 42.19M | 72.64M | 669.9K |
Add to Watchlist
Select watchlists to add or remove CRBP